The patient with hepatic steatosis associated with metabolic dysfunctions in the context of the principle of equity

Abstract

The steatotic liver disease associated with metabolic dysfunctions (SLDAMD) raises a number of moral challenges for the health system in general, and for clinicians in particular. One of these involves interdisciplinary debates regarding the distribution and equitable access to medical services. The approach to non-alcoholic hepatic steatosis in the context of the principle of equity for optimizing personalized medical care for the patient with steatotic liver disease. The study represents a synthesis of various scientific works that address ethical issues regarding adherence to the principle of equity in the context of non-alcoholic steatotic liver disease, identified in databases such as: Research4Life, PubMed, MedLine and JSTOR. Analytical, comparative, and hermeneutic methods were applied . The study represents a synthesis of various scientific works that address ethical issues regarding adherence to the principle of equity in the context of non-alcoholic steatotic liver disease, identified in databases such as: Research4Life, PubMed, MedLine and JSTOR. Analytical, comparative, and hermeneutic methods were applied . The implementation of the principle of equity in the allocation of resources to the targeted patients advances the moral obligation not to discriminate against on the basis of alleged fault. The allocation must be based on clinical and social criteria, not on judgments regarding harmful behaviors.